UroGen Pharma Ltd. (URGN)
NASDAQ: URGN
· Real-Time Price · USD
14.35
2.32 (19.29%)
At close: Jun 16, 2025, 3:59 PM
14.34
-0.07%
Pre-market: Jun 17, 2025, 05:19 AM EDT
UroGen Pharma Revenue
UroGen Pharma reported an annual revenue of $90.4M, reflecting a 9.29% growth. For the quarter ending March 31, 2025, UroGen Pharma generated $20.25M in revenue.
Revenue (ttm)
$90.4M
Revenue Growth
9.29%
Price / Sales Ratio
5.05
Revenue / Employee
$386.32K
Employees
234
Market Cap
661.64M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|